Impact of Vortioxetine on severity, cognitive dysfunctions, and functionality in patients with major depression: a real world experience from Pakistan
Abstract
PREVIDA stands for Pakistani study on Real world Evidence with Vortioxetine in major Depression in Asia.
Anywhere in the world, a clinician’s and a patient’s real-world experience with antidepressant treatment is expected to take place minimally in the following spheres:
- Impact on severity of depression.
- Improvement in functioning at cognitive level, work performance, and productivity.
- Safety and tolerability
- Treatment adherence
- Cost of treatment
In the PREVIDA study we have studied the performance of vortioxetine as a medication intervention in depression on all of the above spheres across Pakistan on almost 500 patients. The manufacturers provided the drug to patients free of cost over three months.
Downloads
Copyright © JPPS. Published by Pakistan Psychiatric Society
Licensing: This work is licensed under Creative Commons Attribution-NonCommercial 4.0 International License
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
